首页> 美国卫生研究院文献>Journal of the Endocrine Society >SUN-582 Effect of the Combination of Conjugated Estrogens and Bazedoxifene on Muscle and Serum Lipidome in Obese Postmenopausal Women: A Placebo-Controlled Randomized Pilot Trial
【2h】

SUN-582 Effect of the Combination of Conjugated Estrogens and Bazedoxifene on Muscle and Serum Lipidome in Obese Postmenopausal Women: A Placebo-Controlled Randomized Pilot Trial

机译:Sun-582共轭雌激素和Bazedoxifene组合在肥胖绝经后妇女的肌肉和血清脂质组合的影响:安慰剂控制随机试验试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Background and Objectives: Menopause is characterized by estrogen deficiency and predisposes women to weight gain and metabolic disturbances including lipid abnormalities. Orally-administered estrogens increase high-density lipoprotein (HDL) and triglycerides (TG) cholesterol and decreases low-density lipoprotein (LDL) cholesterol levels. The increase in serum TGs is not well understood. The objective of this study was to assess the effect of CE/BZA on serum and skeletal muscle lipid species in obese postmenopausal women.
机译:背景和目标:更年期的特征在于雌激素缺乏,并且易于女性重量增加和代谢紊乱,包括脂质异常。口服施用的雌激素增加高密度脂蛋白(HDL)和甘油三酯(Tg)胆固醇,并降低低密度脂蛋白(LDL)胆固醇水平。血清TGS的增加尚不清楚。本研究的目的是评估CE / BZA对肥胖绝经妇女血清和骨骼肌脂质物种的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号